#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Liposarcoma Fusarium infection Antithrombin III deficiency Squamous cell carcinoma of the hypopharynx Neuropathic arthropathy Waldenstrom's macroglobulinaemia Neuromyelitis optica spectrum disorder Chondrosarcoma metastatic Small intestine adenocarcinoma Renal transplant Renal cancer metastatic Fragile X syndrome Neuroendocrine carcinoma Adenomatous polyposis coli Head and neck cancer More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage II Mantle cell lymphoma refractory – Treatment Atypical haemolytic uraemic syndrome – Basic Information MELAS syndrome – Basic Information Haemophilia – Diagnostics Inclusion body myositis – Life with Disease Nephroblastoma – Life with Disease Marfan’s syndrome – Trials in Disease Rhabdomyosarcoma – Life with Disease Mantle cell lymphoma stage III – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Crisantaspase Elacestrant Glucose Monohydrate Ph. Eur. Ag-946 BW-20805 Cladribine Terlipressin HTL0022537 METHYLPHENIDATE [18F]Fapi-74 GSK5764227 Deupirfenidone Tas3351 CARBACHOL Disulfiram Ep0031 Ipatasertib NIZUBAGLUSTAT Glucose Human Serum Albumin 5% More therapies…

    Learn about Your Condition

    COVID-19 Cerebral haemorrhage Raynaud's phenomenon Herpes virus infection Porphyria non-acute Growth hormone deficiency Thrombolysis Hypopituitarism Oesophageal adenocarcinoma Psoriasis Lymphocytic lymphoma Skin neoplasm excision Benign neoplasm of ureter Spinal cord injury Hip fracture More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effects of Botulinum Toxin A for Improving Arm Function in Patients with Chronic Stroke

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Cerebrovascular accident
    Investigated Drugs:
    • Botulinum Toxin Type A – Haemagglutinin Complex
    France

  • Study on the Safety and Tolerability of INP20 for Peanut Allergy in Patients

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Food allergy
    Spain

  • Study on Using Nicotine Electronic Cigarettes and Varenicline for Smoking Cessation in Smokers of 10+ Cigarettes Daily

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Varenicline
    France

  • Study of Bemarituzumab with Irinotecan, Paclitaxel, Ramucirumab, or Trifluridine/Tipiracil for Advanced Stomach or Gastroesophageal Cancer in Patients After Chemotherapy

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Bemarituzumab
    • Ramucirumab
    • Irinotecan
    Germany Spain

  • Study on Gene Therapy for Patients with RAG1-Deficient Severe Combined Immunodeficiency Using RAG1-LV-CD34+ Cells

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Autologous haematopoietic stem cell transplant
    Italy The Netherlands Poland Spain

  • Study on the Safety and Effectiveness of Peginterferon Alfa-2a and Ruxolitinib for Newly Diagnosed Polycythemia Vera Patients

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Polycythaemia vera
    Investigated Drugs:
    • Ruxolitinib
    • Peginterferon Alfa-2A
    Denmark
Previous Page
1 … 844 845 846 847 848 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!